bpc-157 clinical evidence human studies The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity Here's a nice graphic on
Description
Of these, approximately 43,448 participants [21,720 Pfizer-BioNTech COVID-19 Vaccine (30 mcg modRNA) encoding the viral spike (S) glycoprotein of SARS-CoV-2
In other words, it's a medication that targets and binds to the receptors for the GLP-1 peptide, which is part of the bodily systems that regulate hunger and satiation, as well as blood sugar control
Artursson P, Magnusson C
20 units = 500mcg
